Attached files

file filename
EX-3.1 - CERTIFICATE - BIOVEST INTERNATIONAL INCd313222dex31.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 7, 2012

 

 

BIOVEST INTERNATIONAL, INC.

(Exact Name of Registrant as Specified in Charter)

 

 

 

Delaware   00-11480   41-1412084

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

324 South Hyde Park Avenue, Suite 350

Tampa, FL 33606

(Address of Principal Executive Offices; Zip Code)

Registrant’s telephone number, including area code: (813) 864-2554

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


BIOVEST INTERNATIONAL, INC.

FORM 8-K

 

Item 3.03. Material Modification to Rights of Security Holders

 

Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

On March 7, 2012, following its 2012 Annual Meeting of Shareholders (which is discussed in additional detail below), Biovest International, Inc. (the “Company”) filed with the Secretary of State of the State of Delaware a Certificate of Amendment of the Amended and Restated Certificate of Incorporation of the Company (the “Certificate of Amendment”). The Certificate of Amendment, which was effective as of March 7, 2012, (a) increased the number of shares of common stock that the Company is authorized to issue from 300,000,000 shares to 500,000,000 shares and (b) correspondingly increased the overall number of shares of capital stock that the Company is authorized to issue from 350,000,000 shares to 550,000,000 shares.

The foregoing does not purport to be a complete description of the Certificate of Amendment and is qualified in its entirety by reference to the full text of the Certificate of Amendment which is filed as Exhibit 3.1 to this Form 8-K.

 

Item 5.07. Submission of Matters to a Vote of Security Holders

On March 7, 2012, the Company held its 2012 Annual Meeting of Shareholders (the “Annual Meeting”). At the Annual Meeting, the shareholders elected the eight persons identified below to serve as directors of the Company to hold office until the Company’s 2013 Annual Meeting or until their successors are duly elected and qualified.

In addition to the election of directors (Proposal No. 1), the shareholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation to increase the number of shares of common stock, $0.01 par value per share, that the Company is authorized to issue from 300,000,000 shares to 500,000,000 shares and to correspondingly increase the overall number of shares of capital stock that the Company is authorized to issue from 350,000,000 shares to 550,000,000 shares (Proposal No. 2), and ratified the Company’s appointment of Cherry, Bekaert & Holland, L.L.P. as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2012 (Proposal No. 3).

Proposal No. 1 - Election of Directors

 

     For      % Voted
For
    Withheld      % Voted
Withheld
    Broker
Non-Votes
 

Francis E. O’Donnell, Jr.

     94,032,296         99.93     68,591         0.07     19,799,656   

Ronald E. Osman

     93,953,206         99.84     147,681         0.16     19,799,656   

John Sitilides

     94,027,296         99.92     73,591         0.08     19,799,656   

Jeffrey A. Scott

     94,032,296         99.93     68,591         0.07     19,799,656   

Christopher C. Chapman

     94,021,296         99.92     79,591         0.08     19,799,656   

Peter J. Pappas, Sr.

     93,443,296         99.30     657,591         0.70     19,799,656   

Raphael J. Mannino

     94,009,296         99.90     91,591         0.10     19,799,656   

Edmund C. King

     93,441,296         99.30     659,591         0.70     19,799,656   

 

2


Proposal No. 2 – Approval of the amendment to the Company’s Amended and Restated Certificate of Incorporation to increase the number of shares of common stock, $0.01 par value per share, that the Company is authorized to issue from 300,000,000 shares to 500,000,000 shares and to correspondingly increase the overall number of shares of capital stock that the Company is authorized to issue from 350,000,000 shares to 550,000,000 shares

 

     For      Against      Abstain      Broker
Non-Votes
 

Total Shares Voted

     111,268,806         2,616,091         15,646         0   

Proposal No. 3 - Ratification of the Company’s appointment of Cherry, Bekaert & Holland, L.L.P. as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2012

 

     For      Against      Abstain  

Total Shares Voted

     113,324,534         559,856         16,153   

 

Item 9.01. Financial Statements and Exhibits

See the Exhibit Index set forth below for a list of exhibits included with this Form 8-K.

 

3


Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

BIOVEST INTERNATIONAL, INC.
By:  

/s/ Samuel S. Duffey

 

Samuel S. Duffey, Esq.

Chief Executive Officer, President and General Counsel

Date: March 8, 2012

 

4


EXHIBIT INDEX

 

Exhibit

Number

  

Description

3.1    Certificate of Amendment of Amended and Restated Certificate of Incorporation of Biovest International, Inc.

 

5